Close

T2 Biosystems (TTOO) received an Intention to Grant a European Patent for EP Appl. No. 17205422.3, titled: METHODS FOR AMPLIFYING AND DETECTING PATHOGEN NUCLEIC ACID IN A WHOLE BLOOD SAMPLE - Patent E

Go back to T2 Biosystems (TTOO) received an Intention to Grant a European Patent for EP Appl. No. 17205422.3, titled: METHODS FOR AMPLIFYING AND DETECTING PATHOGEN NUCLEIC ACID IN A WHOLE BLOOD SAMPLE - Patent E
(NASDAQ: TTOO) Delayed: 2.99 +0.05 (1.70%)
Previous Close $2.94    52 Week High $12.00 
Open $2.94    52 Week Low $4.92 
Day High $3.00    P/E N/A 
Day Low $2.88    EPS $0.00 
Volume 106,826